Greenness, Whiteness, and Sustainability Profiling of an Ethanol-Based RP-HPLC Method for Atorvastatin and Clopidogrel in Pharmaceutical Tablets

Sura, Ramya Sri and Archana, K. and Sirisha, Nukam (2026) Greenness, Whiteness, and Sustainability Profiling of an Ethanol-Based RP-HPLC Method for Atorvastatin and Clopidogrel in Pharmaceutical Tablets. Current Green Chemistry, 13. ISSN 22133461

[thumbnail of BMS-CGC-2025-175-MS (Final) (1).pdf] Text
BMS-CGC-2025-175-MS (Final) (1).pdf

Download (921kB)

Abstract

Greenness, Whiteness, and Sustainability Profiling of an Ethanol-Based RP-HPLC Method for Atorvastatin and Clopidogrel in Pharmaceutical Tablets Ramya Sri Sura K. Archana Nukam Sirisha

Atorvastatin calcium and clopidogrel bisulfate were regularly prescribed together in a fixed dose combination for a wide range of cardiovascular therapies. A thorough literature review of existing methods suggested that quantifying this combination depends highly on acetonitrile, which is a hazardous solvent. Green analytical chemistry helps to minimise the use of solvents and replace conventional solvents with green solvents to explore the greener and safer analytical performance. In the current study, a greener method was developed with a Waters Xterra RP18 column and a mobile phase of 10mM potassium phosphate buffer in the ratio of 70:30 v/v. The flow rate was set to 1.2 mL/min, the run time was 6 minutes, and the wavelength was 230 nm. Both the drugs expressed good separation with a retention time of 2.152 minutes and 3.646 minutes. The linearity was within the limits with the regression values of 0.9998 and 0.9996. The precision stayed below 1% RSD, and the accuracy was also within the allowed limits. The tablets showed drug content close to the label. Some green tools were checked to see the environmental impact. They all showed that the method is greener because ethanol was used instead of acetonitrile. The method is simple and steady and can be used easily for routine work.
03 18 2026 LiveAll1 1 10.2174/BSP_crossmark_policy eurekaselect.com true Peer Reviewed Double blind Checked with iThenticate 2025-10-24 2025-12-05 2025-12-11 2026-03-18 10.2174/0122133461442405260126073401 https://www.eurekaselect.com/251228/article https://www.eurekaselect.com/251228/article https://www.eurekaselect.com/article/download?doi=10.2174/0122133461442405260126073401 https://www.eurekaselect.com/article/download?doi=10.2174/0122133461442405260126073401 https://www.eurekaselect.com/article/download?doi=10.2174/0122133461442405260126073401 https://www.eurekaselect.com/article/download?doi=10.2174/0122133461442405260126073401 https://www.eurekaselect.com/article/download?doi=10.2174/0122133461442405260126073401 https://www.eurekaselect.com/article/download?doi=10.2174/0122133461442405260126073401 https://www.eurekaselect.com/251228/article

Item Type: Article
Subjects: Pharmaceutical Chemistry and Analysis > Pharmaceutical Analysis
Domains: Pharmaceutical Chemistry and Analysis
Depositing User: Mr IR Admin
Date Deposited: 09 May 2026 10:42
Last Modified: 11 May 2026 06:55
URI: https://ir.vistas.ac.in/id/eprint/14422

Actions (login required)

View Item
View Item